Protozoa: Trichomonas vaginalis (Trichomoniasis) Giardia lamblia (Giardiasis) Entamoeba histolytica (Amoebiasis) Pharmacokinetics Absorption: Well absorbed orally Distribution: Widely distributed (including CNS, liver, and abscesses) Metabolism: In the liver Excretion: Mainly via urine (may darken urine) Indications / Uses Anaerobic bacterial infections Brain abscess Pelvic infections Intra-abdominal infections Aspiration pneumonia Bacterial vaginosis Protozoal infections Amoebic dysentery Giardiasis Trichomoniasis Helicobacter pylori therapy (as part of triple or quadruple therapy) Pseudomembranous colitis caused by Clostridioides difficile (alternative to vancomycin) Dosage (Adults typical) Anaerobic infections: 400500 mg every 8 hours for 710 days Amoebiasis: 500750 mg every 8 hours for 710 days Giardiasis: 250 mg every 8 hours for 57 days Trichomoniasis: 2 g single dose (or 400 mg every 8 hours for 7 days) (Dosage may vary based on infection type and patient factors.) Adverse Effects Gastrointestinal: Nausea, metallic taste, dry mouth, vomiting, diarrhea Neurological: Headache, dizziness, peripheral neuropathy (with prolonged use) Other: Dark or reddish-brown urine (harmless) Furry tongue or oral thrush Hypersensitivity reactions (rare) Contraindications Hypersensitivity to metronidazole First trimester of pregnancy (use with caution) Breastfeeding (may need temporary discontinuation) Drug Interactions Alcohol: Causes disulfiram-like reaction (nausea, vomiting, flushing) Warfarin: Potentiates anticoagulant effect (increased bleeding risk) Phenytoin / Phenobarbital: Reduce metronidazole levels Precautions Avoid alcohol during treatment and for 48 hours after completion Use with caution in hepatic impairment Monitor for neurological symptoms with long-term therapy Key Point Metronidazole is highly effective against anaerobic and protozoal infections, but never mix it with alcohol due to the severe disulfiram-like reaction

The peptide's natural occurrence in the body, well-established safety profile from decades of topical use and clinical research, and remarkable breadth of beneficial biological effects make it a compelling example of a naturally derived regenerative peptide with both proven cosmetic applications and ongoing exploration of broader therapeutic potential
Scalp skin is thinner than facial skin and more sensitive at depth
BMC Public Health (2015) 15:914
& DeLuca, N
If you are currently receiving peptide therapy or were considering it as part of your surgical recovery plan, here is what you need to know: As the FDA peptide regulations 2026 phase out the compounded use of BPC-157, TB-500, KPV, MOTs-c, and GHK-Cu, it is important to recognize that the goals of these therapiesenhanced healing, reduced inflammation, and metabolic supportcan still be achieved through other means